| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |